BARNWELL INDUSTRIES INC (BRN)
US0682211000 - Common Stock
BRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. While BRN seems to be doing ok healthwise, there are quite some concerns on its profitability. BRN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BRN has reported negative net income.
In the past year BRN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BRN reported negative net income in multiple years.
Of the past 5 years BRN 4 years had a positive operating cash flow.
1.2 Ratios
BRN has a Return On Assets of -7.75%. This is amonst the worse of the industry: BRN underperforms 89.67% of its industry peers.
Looking at the Return On Equity, with a value of -14.95%, BRN is doing worse than 85.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.75% | ||
| ROE | -14.95% | ||
| ROIC | N/A |
ROA(3y)12.56%
ROA(5y)-12.29%
ROE(3y)29.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of BRN (34.09%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BRN has grown nicely.
The Profit Margin and Operating Margin are not available for BRN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y1.55%
2. Health
2.1 Basic Checks
BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BRN has more shares outstanding
BRN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of 1.61, we must say that BRN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.61, BRN is in line with its industry, outperforming 49.77% of the companies in the same industry.
BRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.61 |
ROIC/WACCN/A
WACC9.02%
2.3 Liquidity
BRN has a Current Ratio of 1.37. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BRN (1.37) is comparable to the rest of the industry.
BRN has a Quick Ratio of 1.37. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
BRN has a Quick ratio of 1.37. This is in the better half of the industry: BRN outperforms 65.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for BRN have decreased strongly by -148.29% in the last year.
The Revenue for BRN has decreased by -19.33% in the past year. This is quite bad
BRN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.68% yearly.
EPS 1Y (TTM)-148.29%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-160.73%
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y11.51%
Revenue growth 5Y21.68%
Revenue growth Q2Q-15.06%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BRN. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRN is valued a bit more expensive than 69.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.04 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.28%, BRN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.80, BRN has a dividend in line with its industry peers.
BRN's Dividend Yield is comparable with the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
5.2 History
The dividend of BRN decreases each year by -19.19%.
BRN has paid a dividend for at least 10 years, which is a reliable track record.
BRN has decreased its dividend recently.
Dividend Growth(5Y)-19.19%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of BRN are negative and hence is the payout ratio. BRN will probably not be able to sustain this dividend level.
DP-22.07%
EPS Next 2YN/A
EPS Next 3YN/A
BARNWELL INDUSTRIES INC
NYSEARCA:BRN (5/17/2024, 7:04:01 PM)
After market: 2.6 +0.04 (+1.56%)2.56
-0.07 (-2.66%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap25.75M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.75% | ||
| ROE | -14.95% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.09% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-148.29%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y11.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y